Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Other Non-Current Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Non-Current Assets for 5 consecutive years, with $46000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets fell 96.22% to $46000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $46000.0, a 96.22% decrease, with the full-year FY2024 number at $1.2 million, down 94.2% from a year prior.
  • Other Non-Current Assets was $46000.0 for Q3 2025 at Werewolf Therapeutics, down from $895000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $21.0 million in Q4 2023 to a low of $46000.0 in Q3 2025.
  • A 5-year average of $2.0 million and a median of $1.2 million in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: soared 1423.41% in 2023, then plummeted 96.22% in 2025.
  • Werewolf Therapeutics' Other Non-Current Assets stood at $1.2 million in 2021, then rose by 14.24% to $1.4 million in 2022, then soared by 1423.41% to $21.0 million in 2023, then plummeted by 94.2% to $1.2 million in 2024, then tumbled by 96.23% to $46000.0 in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Other Non-Current Assets are $46000.0 (Q3 2025), $895000.0 (Q2 2025), and $179000.0 (Q1 2025).